Dr. Joshua Walker, co-author on 2 abstracts to be presented @ Society for Immunotherapy of Cancer
08/28/17 Portland, Ore.
Dr. Joshua Walker is co-author on 2 original abstracts to be presented at the 32nd Annual Meeting of the Society for Immunotherapy of Cancer, held Nov 8-12, 2017 @ the Gaylord National Hotel &Convention Center in National Harbor, MD. The presentation titles are: 1) "Combination radiotherapy and αOX40/αCTLA-4 immunotherapy reverses anergy and prevents development of functional exhaustion within tumor-specific CD8 T cells" to be presented on behalf of Joshua M Walker, Melissa J Kasiewicz, Courtney L Mick, and William L Redmond;ns 2) "Combination of NKTR-214 and radiotherapy (RT) to reverse anergy and expand tumor-specific CD8 T Cells" on behalf of Joshua M. Walker, Michael J. McNamara, Melissa Kasiewicz, Ian Hilgart-Martiszus, Ute Hoch, Deborah H. Charych, William L. Redmond. These papers are a collaboration between the OHSU Knight Cancer Institute's Dept. of Radiation Medicine, the Earle A. Chiles Research Institute, & Nektar Therapeutics, San Francisco, CA